Clinical Laserthermia Systems AB (publ) (CLS-B.ST)
SEK 3.84
(-2.04%)
SEK 3.84
(-2.04%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -66.45 Million | -70.68 Million | -66.17 Million | -55.4 Million | -39.12 Million | -38.72 Million |
| Net Income | -79.79 Million | -70.68 Million | -63.61 Million | -57.93 Million | -43.37 Million | -32.85 Million |
| Depreciation & Amortization | 2.7 Million | 2.45 Million | 683.5 Thousand | 3.05 Million | 2.68 Million | 209 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | - | - |
| Other non-cash items | 16.04 Million | -2.45 Million | -3.24 Million | -524 Thousand | 1.57 Million | 32.64 Million |
| Investing Cash Flow | -5.49 Million | -886 Thousand | -408 Thousand | -508 Thousand | -40 Thousand | -2.37 Million |
| Investments in PPE | -5.49 Million | -562 Thousand | -555 Thousand | -348 Thousand | - | -2.37 Million |
| Acquisitions | - | - | - | 160 Thousand | - | - |
| Investment purchases | - | -324 Thousand | - | -198 Thousand | -40 Thousand | - |
| Sales/Maturities of investments | - | - | 147 Thousand | 38 Thousand | - | - |
| Other Investing Activities | -3.35 Million | -324 Thousand | -262 Thousand | -160 Thousand | -40 Thousand | -2.33 Million |
| Financing Cash Flow | 76.69 Million | 61.84 Million | 85.87 Million | 62.02 Million | 20.32 Million | 49.86 Million |
| Debt repayment | -30.67 Million | -200 Thousand | -400 Thousand | -15.4 Million | -400 Thousand | -400 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 107.37 Million | 57.04 Million | 71.27 Million | 62.42 Million | 726 Thousand | 50.26 Million |
| Other Financing Activities | 107.37 Million | 5 Million | 15 Million | 15 Million | 20 Million | 50.26 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 10.44 Million | 31.16 Million | 11.87 Million | 5.76 Million | 24.42 Million | 15.64 Million |
| Cash at end of period | 15.33 Million | 10.58 Million | 31.16 Million | 11.87 Million | 5.76 Million | 24.42 Million |
| Capital Expenditure | -5.49 Million | -562 Thousand | -555 Thousand | -348 Thousand | - | -2.37 Million |
| Effect of forex changes on cash | 139.99 Thousand | -10.84 Million | - | - | 172 Thousand | 16 Thousand |
| Net cash flow / Change in cash | 4.88 Million | -20.57 Million | 19.29 Million | 6.11 Million | -18.66 Million | 8.78 Million |
| Free Cash Flow | -71.95 Million | -71.25 Million | -66.73 Million | -55.75 Million | -39.12 Million | -41.1 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.96 Million | -13.59 Million | -12.39 Million | -79.79 Million | -25.25 Million | -16.8 Million |
| Depreciation & Amortization | 605 Thousand | 604 Thousand | 603 Thousand | 2.7 Million | 737 Thousand | 675 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -11.36 Million | - | - | - | - | - |
| Other non-cash items | 11.87 Million | -1.02 Million | -7.52 Million | 16.04 Million | 13.17 Million | -7.82 Million |
| Investing Cash Flow | -2.24 Million | -1.87 Million | -6000.00 | -5.49 Million | -2.08 Million | -1.82 Million |
| Investments in PPE | -278 Thousand | -1.87 Million | -6000.00 | -5.49 Million | -2.08 Million | -1.82 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -6000.00 | -3.35 Million | -1.06 Million | -1.17 Million |
| Financing Cash Flow | 17.71 Million | 12.2 Million | 20.85 Million | 76.69 Million | - | 49.1 Million |
| Debt repayment | -12.5 Million | -12.5 Million | - | -30.67 Million | - | -43.42 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -292 Thousand | - | - | - | - |
| Common Stock Issuance | 30.21 Million | -292 Thousand | 20.85 Million | 107.37 Million | - | 92.53 Million |
| Other Financing Activities | - | - | 20.85 Million | 107.37 Million | - | 92.53 Million |
| Accounts receivables | 5.3 Million | - | - | - | - | - |
| Accounts payables | -16.67 Million | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 11.97 Million | 15.65 Million | 15.33 Million | 10.44 Million | 30.23 Million | 5.76 Million |
| Cash at end of period | 15.58 Million | 11.97 Million | 15.65 Million | 15.33 Million | 15.33 Million | 30.23 Million |
| Capital Expenditure | -278 Thousand | -1.87 Million | -6000.00 | -5.49 Million | -2.08 Million | -1.82 Million |
| Effect of forex changes on cash | - | - | - | 139.99 Thousand | - | 1.13 Million |
| Net cash flow / Change in cash | 3.61 Million | -3.68 Million | 322 Thousand | 4.88 Million | -14.89 Million | 24.46 Million |
| Free Cash Flow | -12.13 Million | -15.89 Million | -20.53 Million | -71.95 Million | -14.89 Million | -25.77 Million |
600771
TRCK
8295
0348
SUDARSCHEM
600516